Download from app store
We have detected that you are using an Ad Blocker.
PracticeUpdate is free to end users but we rely on advertising to fund our site. Please consider supporting PracticeUpdate by whitelisting us in your ad blocker.
We have sent a message to the email address you have provided, . If this email is not correct, please update your settings with your correct address.
The email address you provided during registration, , does not appear to be valid. Please update your settings with a valid address before to continue using PracticeUpdate.
Please provide your AHPRA Number to ensure that you are given the correct level of access to our site.
Published in Dermatology

Journal Scan / Research · March 22, 2022

Chemoprevention of Cutaneous Squamous Cell Carcinoma in Solid Organ Transplant Recipients Using Topical Sirolimus

Journal of the American Academy of Dermatology


Additional Info

Journal of the American Academy of Dermatology
Chemoprevention of cutaneous squamous cell carcinoma and its precursors in solid organ transplant recipients using topical sirolimus: a randomized, double-blind, placebo-controlled pilot trial
J Am Acad Dermatol 2022 Feb 24;[EPub Ahead of Print], S Chong, HY Wong, A Althabteh, C Cox, P Stevenson, S Brown, A Griffin, N Isbel, G Siller, HP Soyer, H Schaider, E Roy, S Campbell, AC Green, K Khosrotehrani

From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine.

Further Reading